Vaxart, Inc. – Trademark Portfolio

Entity Type: 03

Vaxart, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include VAAST, VAXART, and THE PILL THAT MOVES THE NEEDLE. The owner is based in South San Francisco, CA.

Suite 405

395 Oyster Point

South San Francisco, CA 94080

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Vaxart, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Vaxart, Inc. have?

Vaxart, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.

What trademark classes does Vaxart, Inc. file in?

Vaxart, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Vaxart, Inc.'s most well-known trademarks?

Vaxart, Inc.'s registered trademark portfolio includes well-known marks such as VAAST, VAXART, and THE PILL THAT MOVES THE NEEDLE. These are among 3 currently registered trademarks in the portfolio.

What is Vaxart, Inc.'s trademark registration success rate?

Vaxart, Inc. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.